Authors:
Valverde, O
Noble, F
Beslot, F
Dauge, V
Fournie-Zaluski, MC
Roques, BP
Citation: O. Valverde et al., Delta(9)-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect, EUR J NEURO, 13(9), 2001, pp. 1816-1824
Authors:
David-Basei, C
Bischoff, L
Fournie-Zaluski, MC
Roques, BP
Citation: C. David-basei et al., Synthesis of [3(R)-amino-2(S)-sulfhydryl-5-sulfonate]-pentanoyl-(S)-3-[I-125]-iodotyrosyl-(S)-aspartic acid: a radiolabelled inhibitor of aminopeptidase A, J LABEL C R, 44(1), 2001, pp. 89-98
Authors:
Noble, F
Banisadr, G
Jardinaud, F
Popovici, T
Lai-Kuen, R
Chen, H
Bischoff, L
Parsadaniantz, SM
Fournie-Zaluski, MC
Roques, BP
Citation: F. Noble et al., First discrete autoradiographic distribution of aminopeptidase N in various structures of rat brain and spinal cord using the selective iodinated inhibitor [I-125]RB 129, NEUROSCIENC, 105(2), 2001, pp. 479-488
Authors:
Boudinot, E
Morin-Surun, MP
Foutz, AS
Fournie-Zaluski, MC
Roques, BP
Denavit-Saubie, M
Citation: E. Boudinot et al., Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration, PAIN, 90(1-2), 2001, pp. 7-13
Citation: V. Dauge et al., Mutant mice lacking the cholecystokinin(2) receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphine, NEUROSCI L, 306(1-2), 2001, pp. 41-44
Authors:
Luciani, N
De Rocquigny, H
Turcaud, S
Romieu, A
Roques, BP
Citation: N. Luciani et al., Highly sensitive and selective fluorescence assays for rapid screening of endothelin-converting enzyme inhibitors, BIOCHEM J, 356, 2001, pp. 813-819
Authors:
Tiraboschi, G
Fournie-Zaluski, MC
Roques, BP
Gresh, N
Citation: G. Tiraboschi et al., Intramolecular chelation of Zn2+ by alpha- and beta-mercaptocarboxamides. A parallel ab initio and polarizable molecular mechanics investigation. assessment of the role of multipole transferability, J COMPUT CH, 22(10), 2001, pp. 1038-1047
Authors:
Nieto, MM
Wilson, J
Walker, J
Benavides, J
Fournie-Zaluski, MC
Roques, BP
Noble, F
Citation: Mm. Nieto et al., Facilitation of enkephalins catabolism inhibitor-induced antinociception by drugs classically used in pain management, NEUROPHARM, 41(4), 2001, pp. 496-506
Authors:
Bombarda, E
Morellet, N
Cherradi, H
Spiess, B
Bouaziz, S
Grell, E
Roques, BP
Mely, Y
Citation: E. Bombarda et al., Determination of the pK(a), of the four Zn2+-coordinating residues of the distal finger motif of the HIV-1 nucleocapsid protein: Consequences on the binding of Zn2+ (vol 310, pg 659, 2001), J MOL BIOL, 311(5), 2001, pp. 1105-1105
Authors:
Bombarda, E
Morellet, N
Cherradi, H
Spiess, B
Bouaziz, S
Grell, E
Roques, BP
Mely, Y
Citation: E. Bombarda et al., Determination of the pK(a) of the four Zn2+-coordinating residues of the distal finger motif of the HIV-1 nucleocapsid protein: Consequences on the binding of Zn2+, J MOL BIOL, 310(3), 2001, pp. 659-672
Citation: C. Tisne et al., Heteronuclear NMR studies of the interaction of tRNA(3)(Lys) with HIV-1 nucleocapsid protein, J MOL BIOL, 306(3), 2001, pp. 443-454
Authors:
Chen, HX
Noble, F
Roques, BP
Fournie-Zaluski, MC
Citation: Hx. Chen et al., Long lasting antinociceptive properties of enkephalin degrading enzyme (NEP and APN) inhibitor prodrugs, J MED CHEM, 44(21), 2001, pp. 3523-3530
Authors:
Jacotot, E
Ferri, KF
El Hamel, C
Brenner, C
Druillennec, S
Hoebeke, J
Rustin, P
Metivier, D
Lenoir, C
Geuskens, M
Vieira, HLA
Loeffler, M
Belzacq, AS
Briand, JP
Zamzami, N
Edelman, L
Xie, ZH
Reed, JC
Roques, BP
Kroemer, G
Citation: E. Jacotot et al., Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein R and Bcl-2, J EXP MED, 193(4), 2001, pp. 509-519
Authors:
Arbin, V
Claperon, N
Fournie-Zaluski, MC
Roques, BP
Peyroux, J
Citation: V. Arbin et al., Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat, BR J PHARM, 133(4), 2001, pp. 495-502
Authors:
Coudore-Civiale, MA
Meen, M
Fournie-Zaluski, MC
Boucher, M
Roques, BP
Eschalier, A
Citation: Ma. Coudore-civiale et al., Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabeticrats, BR J PHARM, 133(1), 2001, pp. 179-185
Citation: C. Anne et al., High-throughput fluorogenic assay for determination of botulinum type B neurotoxin protease activity, ANALYT BIOC, 291(2), 2001, pp. 253-261
Citation: H. Guo et al., Many-body effects in systems of peptide hydrogen-bonded networks and theircontributions to ligand binding: A comparison of the performances of DFT and polarizable molecular mechanics, J PHYS CH B, 104(41), 2000, pp. 9746-9754
Authors:
Spielewoy, C
Gonon, F
Roubert, C
Fauchey, V
Jaber, M
Caron, MG
Roques, BP
Hamon, M
Betancur, C
Maldonado, R
Giros, B
Citation: C. Spielewoy et al., Increased rewarding properties of morphine in dopamine-transporter knockout mice, EUR J NEURO, 12(5), 2000, pp. 1827-1837
Authors:
Valverde, O
Ledent, C
Beslot, F
Parmentier, M
Roques, BP
Citation: O. Valverde et al., Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors, EUR J NEURO, 12(2), 2000, pp. 533-539
Authors:
Shui, XQ
Peek, ME
Lipscomb, LA
Gao, Q
Ogata, C
Roques, BP
Garbay-Jaureguiberry, C
Wilkinson, AP
Williams, LD
Citation: Xq. Shui et al., Effects of cationic charge on three-dimensional structures of intercalative complexes: Structure of a bis-intercalated DNA complex solved by MAD phasing, CURR MED CH, 7(1), 2000, pp. 59-71